Nutex Health Inc. 8-K

What Happened Nutex Health Inc. (NUTX) filed an 8-K disclosing a First Amendment to its Payment Dispute Resolution Services Agreement with HaloMD, L.L.C. The Amendment was entered on July 15, 2026 and is effective retroactively to the Agreement’s June 30, 2026 Effective Date (original Agreement dated May 1, 2024). Key changes include transitioning to a pay-on-collected fee model (instead of payment due on award determination), updating the fee schedule for federal and state net settlements effective July 1, 2026, procedural changes (e.g., HaloMD access to remittance data), and giving Nutex the option to handle dispute resolution in-house or engage other vendors for certain future hospital facilities. The Amendment also extends the Agreement’s initial term through December 31, 2029 with automatic one-year renewals.

Key Details

• Amendment entered July 15, 2026; effective retroactive to June 30, 2026.
• Fee model changed to pay-on-collected and fee schedule amended for settlements obtained on/after July 1, 2026.
• Centers for Medicare & Medicaid Services cut the Federal IDR administrative fee from $115 to $15 per party per dispute, effective June 11, 2026.
• Agreement term extended through December 31, 2029, and Nutex may perform dispute resolution in-house or use other third-party vendors for certain facilities.

Why It Matters These changes are likely to lower Nutex’s arbitration-related costs and shift timing of cash outflows (payments tied to collections rather than award determinations), which can improve short-term cash flow predictability. The CMS reduction in Federal IDR fees further reduces the cost of pursuing independent dispute resolution under the No Surprises Act. Granting Nutex the right to bring services in-house or use other vendors gives the company operational flexibility that could reduce long-term vendor costs or change how disputes are managed—details and financial impact beyond the company’s expectation of reduced arbitration costs were not quantified in the filing.